表紙
市場調查報告書
商品編碼
1028897

全球生物相似藥淋巴球調製器市場報告:2021年版 - COVID-19擴大和到2030年前的變化

Biosimilar Lymphocyte Modulator Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球生物相似藥淋巴球調製器市場相關調查,網羅市場特性,規模與成長,市場區隔,各地各國趨勢,競爭情形,市場佔有率,市場趨勢與策略。還有各地區的市場的實際成果與預測,及加入此市場的主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 生物相似藥淋巴球調製器市場特徵

第3章 生物相似藥淋巴球調製器市場趨勢與策略

第4章 COVID-19對生物相似藥淋巴球調製器的影響

第5章 生物相似藥淋巴球調製器的市場規模與成長

  • 全球生物相似藥淋巴球調製器市場實際成果,2015∼2020年,10億美元
    • 市場促進因素
    • 市場阻礙因素
  • 全球生物相似藥淋巴球調製器市場預測,2020∼2025年,2030年,10億美元
    • 市場促進因素
    • 市場阻礙因素

第6章 生物相似藥淋巴球調製器市場區隔

  • 全球生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • Campath-1H
  • Natalizumab Biosimilar
  • Efalizumab - A1089-Anti-CD11a Bisoimilar
  • Anti-CD38 daratumumab Biosimilar
  • Anti-CS1 elotuzumab Bisoimilar
  • 全球生物相似藥淋巴球調製器市場,各疾病市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 關節炎
  • 糖尿病
  • 多發性骨髓瘤
  • 腸炎
  • 多發性硬化症
  • 乾癬
  • 其他

第7章 生物相似藥淋巴球調製器市場各地區以及各國分析

  • 全球生物相似藥淋巴球調製器市場,各地區,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 全球生物相似藥淋巴球調製器市場,各國,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第8章 亞太地區的生物相似藥淋巴球調製器市場

  • 亞太地區的生物相似藥淋巴球調製器市場概要
  • 地區資訊,COVID-19的影響,市場資訊,背景資訊,政府的積極推動,法規,法規機關,主要的協會,免稅,公司稅結構,投資,主要企業
  • 亞太地區的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第9章 中國的生物相似藥淋巴球調製器市場

  • 中國的生物相似藥淋巴球調製器市場概要
  • 中國的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第10章 印度的生物相似藥淋巴球調製器市場

  • 印度的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第11章 日本的生物相似藥淋巴球調製器市場

  • 日本的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第12章 澳洲的生物相似藥淋巴球調製器市場

  • 澳洲的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第13章 印尼的生物相似藥淋巴球調製器市場

  • 印尼的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第14章 韓國的生物相似藥淋巴球調製器市場

  • 韓國的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第15章 西歐的生物相似藥淋巴球調製器市場

  • 西歐的生物相似藥淋巴球調製器市場概要
  • 西歐的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第16章 英國的生物相似藥淋巴球調製器市場

  • 英國的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第17章 德國的生物相似藥淋巴球調製器市場

  • 德國的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第18章 法國的生物相似藥淋巴球調製器市場

  • 法國的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第19章 東歐的生物相似藥淋巴球調製器市場

  • 東歐的生物相似藥淋巴球調製器市場概要
  • 東歐的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第20章 俄羅斯的生物相似藥淋巴球調製器市場

  • 俄羅斯的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第21章 北美的生物相似藥淋巴球調製器市場

  • 北美的生物相似藥淋巴球調製器市場概要
  • 北美的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第22章 美國的生物相似藥淋巴球調製器市場

  • 美國的生物相似藥淋巴球調製器市場概要
  • 美國的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第23章 南美的生物相似藥淋巴球調製器市場

  • 南美的生物相似藥淋巴球調製器市場概要
  • 南美的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第24章 巴西的生物相似藥淋巴球調製器市場

  • 巴西的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第25章 中東的生物相似藥淋巴球調製器市場

  • 中東的生物相似藥淋巴球調製器市場概要
  • 中東的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第26章 非洲的生物相似藥淋巴球調製器市場

  • 非洲的生物相似藥淋巴球調製器市場概要
  • 非洲的生物相似藥淋巴球調製器市場,各藥物市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第27章 生物相似藥淋巴球調製器市場競爭情形和企業簡介

  • 生物相似藥淋巴球調製器市場競爭情形
  • 生物相似藥淋巴球調製器市場企業簡介
    • Pfizer
    • Biogen
    • Genentech
    • Novartis
    • Celltrion

第28章 生物相似藥淋巴球調製器開發平台分析

第29章 生物相似藥淋巴球調製器市場上主要合併和收購

第30章 生物相似藥淋巴球調製器市場未來展望和潛在性分析

第31章 附錄

目錄
Product Code: h921

Biosimilar Lymphocyte Modulator Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar lymphocyte modulator market.

This report focuses on biosimilar lymphocyte modulator market which is experiencing strong growth. The report gives a guide to the biosimilar lymphocyte modulator market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the biosimilar lymphocyte modulator? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Biosimilar Lymphocyte Modulator market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider biosimilar lymphocyte modulator market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biosimilar lymphocyte modulator market section of the report gives context. It compares the biosimilar lymphocyte modulator market with other segments of the biosimilar lymphocyte modulator market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biosimilar lymphocyte modulator indicators comparison.

Scope

Markets Covered: 1) By Drug: Campath-1H; Natalizumab Biosimilar; Efalizumab - A1089-Anti-CD11a Bisoimilar; Anti-CD38 Daratumumab Biosimilar; Anti-CS1 Elotuzumab Bisoimilar

2) By Disease: Arthritis; Diabetes; Multiple Myeloma; Enterocolitis; Multiple Sclerosis; Psoriasis; Others

Companies Mentioned: Pfizer; Biogen; Genentech; Novartis; Celltrion

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Biosimilar Lymphocyte Modulator Market Characteristics

3. Biosimilar Lymphocyte Modulator Market Trends And Strategies

4. Impact Of COVID-19 On Biosimilar Lymphocyte Modulator

5. Biosimilar Lymphocyte Modulator Market Size And Growth

  • 5.1. Global Biosimilar Lymphocyte Modulator Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Biosimilar Lymphocyte Modulator Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Biosimilar Lymphocyte Modulator Market Segmentation

  • 6.1. Global Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Campath-1H
  • Natalizumab Biosimilar
  • Efalizumab - A1089-Anti-CD11a Bisoimilar
  • Anti-CD38 daratumumab Biosimilar
  • Anti-CS1 elotuzumab Bisoimilar
  • 6.2. Global Biosimilar Lymphocyte Modulator Market, Segmentation By Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Arthritis
  • Diabetes
  • Multiple Myeloma
  • Enterocolitis
  • Multiple Sclerosis
  • Psoriasis
  • Others

7. Biosimilar Lymphocyte Modulator Market Regional And Country Analysis

  • 7.1. Global Biosimilar Lymphocyte Modulator Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Biosimilar Lymphocyte Modulator Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Biosimilar Lymphocyte Modulator Market

  • 8.1. Asia-Pacific Biosimilar Lymphocyte Modulator Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Biosimilar Lymphocyte Modulator Market

  • 9.1. China Biosimilar Lymphocyte Modulator Market Overview
  • 9.2. China Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Biosimilar Lymphocyte Modulator Market

  • 10.1. India Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Biosimilar Lymphocyte Modulator Market

  • 11.1. Japan Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Biosimilar Lymphocyte Modulator Market

  • 12.1. Australia Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Biosimilar Lymphocyte Modulator Market

  • 13.1. Indonesia Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Biosimilar Lymphocyte Modulator Market

  • 14.1. South Korea Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Biosimilar Lymphocyte Modulator Market

  • 15.1. Western Europe Biosimilar Lymphocyte Modulator Market Overview
  • 15.2. Western Europe Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Biosimilar Lymphocyte Modulator Market

  • 16.1. UK Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Biosimilar Lymphocyte Modulator Market

  • 17.1. Germany Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Biosimilar Lymphocyte Modulator Market

  • 18.3. France Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Biosimilar Lymphocyte Modulator Market

  • 19.1. Eastern Europe Biosimilar Lymphocyte Modulator Market Overview
  • 19.2. Eastern Europe Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Biosimilar Lymphocyte Modulator Market

  • 20.1. Russia Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Biosimilar Lymphocyte Modulator Market

  • 21.1. North America Biosimilar Lymphocyte Modulator Market Overview
  • 21.2. North America Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Biosimilar Lymphocyte Modulator Market

  • 22.1. USA Biosimilar Lymphocyte Modulator Market Overview
  • 22.2. USA Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Biosimilar Lymphocyte Modulator Market

  • 23.1. South America Biosimilar Lymphocyte Modulator Market Overview
  • 23.2. South America Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Biosimilar Lymphocyte Modulator Market

  • 24.1. Brazil Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Biosimilar Lymphocyte Modulator Market

  • 25.1. Middle East Biosimilar Lymphocyte Modulator Market Overview
  • 25.2. Middle East Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Biosimilar Lymphocyte Modulator Market

  • 26.1. Africa Biosimilar Lymphocyte Modulator Market Overview
  • 26.2. Africa Biosimilar Lymphocyte Modulator Market, Segmentation By Drug, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Biosimilar Lymphocyte Modulator Market Competitive Landscape And Company Profiles

  • 27.1. Biosimilar Lymphocyte Modulator Market Competitive Landscape
  • 27.2. Biosimilar Lymphocyte Modulator Market Company Profiles
    • 27.2.1. Pfizer
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Biogen
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Genentech
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Novartis
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Celltrion
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Biosimilar Lymphocyte Modulator Pipeline Analysis

29. Key Mergers And Acquisitions In The Biosimilar Lymphocyte Modulator Market

30. Biosimilar Lymphocyte Modulator Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer